- Home
- / Dong-A Socio Holdings
Dong-A Socio Holdings
Revenue
₩881.9 B
FY, 2021
Market Capitalization
₩631.2 B
2023-01-19
Dong-A Socio Holdings Summary
Company summary
- Overview
- Dong-A Socio Holdings (동아쏘시오홀딩스, also known as Dong-A ST) is a company that manufactures and sells pharmaceuticals. It offers nutritious tonics, biomedicines, and drug products. the company also provides clinical trials, medical diagnoses, and disease treatment services.
- Type
- Public
- Status
- Active
- Founded
- 1932
- HQ
- Seoul, KR | view all locations
- Website
- https://en.donga.co.kr/
LocationsView all
3 locations detected
Seoul, Seoul HQ
Korea (Republic of)
64 Cheonhodaero
Cerritos, CA
United States
17215 Studebaker Road, Suite #335
Sao Paulo, SP
Brazil
Av. Roque Petroni Junior 1089, Centro Profissional Morumbi Shopping sala 811 e 813
Dong-A Socio Holdings Financials
Summary financials
- Revenue (FY, 2021)
- ₩881.9B
- Gross profit (FY, 2021)
- ₩337.3B
- Net income (FY, 2021)
- ₩60.5B
- Cash (FY, 2021)
- ₩99.6B
- EBIT (FY, 2021)
- ₩73.1B
- Enterprise value
- $1.1T
